Literature DB >> 23614115

Ovarian stimulation and liver dysfunction: Is a clinical relationship possible? A case of hepatic failure after repeated cycles of ovarian stimulation.

Emilio Giugliano1, Elisa Cagnazzo, Giancarlo Pansini, Fortunato Vesce, Roberto Marci.   

Abstract

Liver damage induced by ovarian stimulation has been demonstrated in some cases reported in the literature. However, there has never been a fruitful debate on this topic. The present manuscript tried to fill this gap. We reported a case of a 35-year-old nulliparous woman admitted to our obstetric emergency room for severe pre-eclampsia. She had been subjected to four cycles of controlled ovarian stimulation for intrauterine insemination. At 32 weeks of gestation, she developed severe pre-eclampsia, which led to HELLP syndrome complicated by fatal liver failure. The etiological link between ovarian stimulation and HELLP syndrome is intriguing. Further investigations are needed to understand whether repeated ovarian stimulation may represent a risk factor in pre-eclamptic patients.

Entities:  

Keywords:  Controlled ovarian stimulation; Endothelial dysfunction; HELLP syndrome; Intrauterine insemination; Liver rupture; Ovarian hyperstimulation syndrome

Year:  2013        PMID: 23614115      PMCID: PMC3630292          DOI: 10.5653/cerm.2013.40.1.38

Source DB:  PubMed          Journal:  Clin Exp Reprod Med        ISSN: 2093-8896


  19 in total

1.  Marked elevation of serum transaminases may be associated with ovarian hyperstimulation syndrome.

Authors:  M R Borgaonkar; J K Marshall
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

2.  Characteristics and treatment of hepatic rupture caused by HELLP syndrome.

Authors:  Ana C P F Araujo; Marcos D Leao; Maria H Nobrega; Patricia F M Bezerra; Flavio V M Pereira; Edailna M M Dantas; George D Azevedo; Selma M B Jeronimo
Journal:  Am J Obstet Gynecol       Date:  2006-03-30       Impact factor: 8.661

3.  In vitro fertilization is associated with an increased risk for preeclampsia.

Authors:  Xi-Kuan Chen; Shi Wu Wen; Jim Bottomley; Graeme N Smith; Arthur Leader; Mark C Walker
Journal:  Hypertens Pregnancy       Date:  2009-02       Impact factor: 2.108

4.  Assisted conception and placental perfusion assessed by uterine artery Doppler at 11-13 weeks' gestation.

Authors:  Ilma F Carbone; Jader J Cruz; Rita Sarquis; Ranjit Akolekar; Kypros H Nicolaides
Journal:  Hum Reprod       Date:  2011-04-12       Impact factor: 6.918

5.  Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome.

Authors:  C D Chen; M Y Wu; H F Chen; S U Chen; H N Ho; Y S Yang
Journal:  Hum Reprod       Date:  2000-01       Impact factor: 6.918

6.  Liver dysfunction in severe ovarian hyperstimulation syndrome.

Authors:  Bogdan Obrzut; Waldemar Kuczyński; Cezary Grygoruk; Lechosław Putowski; Sabina Kluz; Andrzej Skret
Journal:  Gynecol Endocrinol       Date:  2005-07       Impact factor: 2.260

7.  Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

Authors:  B M Sibai; M K Ramadan; I Usta; M Salama; B M Mercer; S A Friedman
Journal:  Am J Obstet Gynecol       Date:  1993-10       Impact factor: 8.661

8.  Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome.

Authors:  Vivian Barak; Uriel Elchalal; Michal Edelstein; Inna Kalickman; Aby Lewin; Yoram Abramov
Journal:  Fertil Steril       Date:  2004-08       Impact factor: 7.329

9.  Transaminitis after treatment with clomiphene citrate: a case report.

Authors:  Caroline Mitchell; Laura Gottlieb
Journal:  J Reprod Med       Date:  2007-05       Impact factor: 0.142

Review 10.  Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS).

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Hum Reprod Update       Date:  2003 Jan-Feb       Impact factor: 15.610

View more
  4 in total

1.  Rescue In Vitro Maturation in Polycystic Ovarian Syndrome Patients Undergoing In Vitro Fertilization Treatment who Overrespond or Underrespond to Ovarian Stimulation: Is It A Viable Option? A Case Series Study.

Authors:  Muhammad Fatum; Marie Eve Bergeron; Caroline Ross; Anni Ding; Ayesha Bhevan; Karen Turner; Tim Child
Journal:  Int J Fertil Steril       Date:  2020-07-15

2.  Renal and Hepatic Functions after A Week of Controlled Ovarian Hyperstimulation during In Vitro Fertilization Cycles.

Authors:  Ilaria Romito; Ferdinando Antonio Gulino; Antonio Simone Laganà; Salvatore Giovanni Vitale; Attilio Tuscano; Gianluca Leanza; Giulia Musmeci; Vito Leanza; Agnese Maria Chiara Rapisarda; Marco Antonio Palumbo
Journal:  Int J Fertil Steril       Date:  2016-11-11

3.  Consequences of twinning induction to Noemi ewes by a recombinant human follicle-stimulating hormone compared with pituitary-derived porcine follicle-stimulating hormone on follicular dynamics, maternal biochemical attributes, and neonatal traits.

Authors:  Moustafa Mohamed Zeitoun; Abdulrahman O El-Dawas; Mohamed A Ateah; Mohamed Ahmed Shehab El-Deen
Journal:  Vet World       Date:  2020-04-08

Review 4.  Management of pregnancy in women with cirrhosis.

Authors:  Mussarat N Rahim; Tasneem Pirani; Catherine Williamson; Michael A Heneghan
Journal:  United European Gastroenterol J       Date:  2021-02-23       Impact factor: 4.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.